SCHEMBL18564997

SCHEMBL18564997

CN(c1ccccc1)c1ccc(-c2ccc(-c3ccc4c5ccccc5n(-c5ccc6ccccc6c5)c4c3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPK10 P53779 5/20 0.36
MAPK9 P45984 4/20 0.36
HTR1D P28221 1/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34
TUBA1A Q71U36 1/20 0.34
TUBA1C Q9BQE3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565003 1.00 KDM4E (0.37) KDM4EATML3MBTL1MAPK10MAPK9
SCHEMBL18565021 0.93 TSPO (0.38) KDM4EATML3MBTL1MAPK10MAPK9
SCHEMBL18564998 0.93 HTR1D (0.38) KDM4EMAPK10MAPK9HTR1DITK
SCHEMBL18565007 0.93 HTR1D (0.38) KDM4EMAPK10MAPK9HTR1DITK
SCHEMBL19735331 0.93 KDM4E (0.37) KDM4EATML3MBTL1MAPK10MAPK9
SCHEMBL18565022 0.93 TSPO (0.38) KDM4EATML3MBTL1MAPK10MAPK9
SCHEMBL18583445 0.92 HTR1D (0.33) KDM4EATML3MBTL1MAPK10MAPK9
SCHEMBL18564991 0.91 KDM4E (0.40) KDM4EATML3MBTL1MAPK10MAPK9
SCHEMBL18564820 0.89 KDM4E (0.46) KDM4EATML3MBTL1RXRARXRB
SCHEMBL19735342 0.89 KDM4E (0.42) KDM4EATML3MBTL1HTR1DTUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 KDM4E 225/4885ATM 3092/4885L3MBTL1 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.